These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 6131925)
1. Interaction of the mouse thyrotrophin receptor with thyrotrophin binding inhibitor immunoglobulins. Luttrell BM J Endocrinol; 1983 Mar; 96(3):481-8. PubMed ID: 6131925 [TBL] [Abstract][Full Text] [Related]
2. Comparison of human and porcine thyroid membranes for radioreceptor assay of bovine thyrotrophin and thyrotrophin-binding inhibiting immunoglobulins. Humphries H; Dirmikis SM; Munro DS J Endocrinol; 1982 Jun; 93(3):371-80. PubMed ID: 6123540 [TBL] [Abstract][Full Text] [Related]
3. [Studies on the radioreceptor assay of TSH: the properties of TSH-binding inhibitor immunoglobulins (TBII) in patients with Hashimoto's thyroiditis (author's transl)]. Endo K Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1275-85. PubMed ID: 228999 [TBL] [Abstract][Full Text] [Related]
4. Thyrotrophin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator. Docter R; Bos G; Visser TJ; Hennemann G Clin Endocrinol (Oxf); 1980 Feb; 12(2):143-53. PubMed ID: 6105023 [TBL] [Abstract][Full Text] [Related]
5. [Studies on the radioreceptor assay of TSH: the properties of TSH-binding inhibitor immunoglobulins (TBII) in patients with Graves' disease (author's transl)]. Endo K Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1261-74. PubMed ID: 228998 [TBL] [Abstract][Full Text] [Related]
7. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. Endo K; Kasagi K; Konishi J; Ikekubo K; Okuno T; Takeda Y; Mori T; Torizuka K J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421 [TBL] [Abstract][Full Text] [Related]
8. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells. Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672 [TBL] [Abstract][Full Text] [Related]
9. Discrepancy between thyroid-stimulating and thyrotropin-binding inhibitory activities of Graves' immunoglobulin Gs assessed in the mouse. Shishiba Y; Ozawa Y; Ohtsuki N; Shimizu T J Clin Endocrinol Metab; 1982 Apr; 54(4):858-62. PubMed ID: 6277983 [TBL] [Abstract][Full Text] [Related]
10. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators. Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871 [TBL] [Abstract][Full Text] [Related]
11. The species specificity of TSH receptor binding antibodies as measured by radioreceptor study. Strakosch CR; Joyner D; Manley SW; Wall JR Clin Endocrinol (Oxf); 1982 Aug; 17(2):173-9. PubMed ID: 6127179 [TBL] [Abstract][Full Text] [Related]
12. Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP. Leedman PJ; Frauman AG; Colman PG; Michelangeli VP Clin Endocrinol (Oxf); 1992 Dec; 37(6):493-9. PubMed ID: 1363083 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease. Cho BY; Shong MH; Yi KH; Lee HK; Koh CS; Min HK Clin Endocrinol (Oxf); 1992 Jun; 36(6):585-90. PubMed ID: 1358483 [TBL] [Abstract][Full Text] [Related]
14. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods. Morris JC; Hay ID; Nelson RE; Jiang NS Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572 [TBL] [Abstract][Full Text] [Related]
15. The interaction of thyrotrophin binding inhibiting immunoglobulins with high and low affinity TSH receptors. Pekonen F; Mäkinen T Acta Endocrinol Suppl (Copenh); 1983; 251():33-7. PubMed ID: 6132509 [TBL] [Abstract][Full Text] [Related]
16. Detection of TSH-binding inhibitor immunoglobulins by using the triton-solubilized receptor from human thyroid membranes. Iida Y; Konishi J; Kasagi K; Kuma K; Torizuka K Endocrinol Jpn; 1982 Apr; 29(2):227-31. PubMed ID: 6127209 [TBL] [Abstract][Full Text] [Related]
17. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951 [TBL] [Abstract][Full Text] [Related]
18. A stable, reproducible radioreceptorassay for thyrotropin binding inhibiting immunoglobulins (TBII). Bliddal H Scand J Clin Lab Invest; 1981 Sep; 41(5):441-9. PubMed ID: 6118939 [TBL] [Abstract][Full Text] [Related]
19. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities. Tamaki H; Amino N; Watanabe Y; Aozasa M; Hayashi H; Tachi J; Miyai K J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274 [TBL] [Abstract][Full Text] [Related]
20. The assay of Graves' immunoglobulins: a comparison of different methods. Hardisty CA; Kendall-Taylor P; Atkinson S; Humphries H; Munro DS Clin Endocrinol (Oxf); 1983 Jun; 18(6):637-44. PubMed ID: 6136348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]